6533b82efe1ef96bd1292a82
RESEARCH PRODUCT
Informing MS patients on treatment options: a consensus on the process of consent taking
Cinzia CordioliPaolo RagonesePietro AnnovazziValentina TomassiniValentina TomassiniSimona MalucchiIlaria PesciClaudio SolaroPaola CavallaLuca ProsperiniG. De LucaLaura BoffaG. T. ManiscalcoDamiano PaolicelliMassimiliano Calabrese 1M. RodegherMarcello MocciaMarcello MocciaDiana FerraroAlice LaroniC. TortorellaAlberto GajofattoEleonora CoccoRoberta FantozziFabio ButtariS. Lo FermoAntonio GalloViviana NocitiMaria Chiara BuscarinuR LanzilloM. Di FilippoClaudio GasperiniV. Torri ClericiM. Gherardisubject
medicine.medical_specialtyConsensusProcess (engineering)media_common.quotation_subjectDermatologyDisease modifying treatment; Informed consent; Multiple sclerosisMultiple sclerosis03 medical and health sciences0302 clinical medicineResource (project management)Informed consentDisease modifying treatmentmedicineHumans030212 general & internal medicineInformed consentEmpowermentmedia_commonPhysician-Patient Relationsbusiness.industryTreatment optionsGeneral MedicineClinical PracticePsychiatry and Mental healthItalyFamily medicineDisease modifying treatment; Informed consent; Multiple sclerosis; Consensus; Humans; Italy; Physician-Patient Relations; Informed Consent; Multiple SclerosisSettore MED/26 - NeurologiaNeurology (clinical)Decision processbusiness030217 neurology & neurosurgerydescription
Abstract\ud In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process.\ud Aims\ud The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice.\ud Results\ud The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-04-02 |